|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/06 | (2006.01) |
| A61K 9/107 | (2006.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1988877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06820561.6 |
| Date of filing the European patent application | 2006-12-18 | |
| (97) | Date of publication of the European application | 2008-11-12 |
| (45) | Date of publication and mention of the grant of the patent | 2014-02-12 |
| (46) | Date of publication of the claims translation | 2014-06-25 |
| (86) | Number | PCT/GB2006/004739 |
| Date | 2006-12-18 |
| (87) | Number | WO 2007/068963 |
| Date | 2007-06-21 |
| (30) | Number | Date | Country code |
| 0525680 | 2005-12-16 | GB |
| (72) |
BROWN, Marc, Barry, GB
CROTHERS, Michael, Edward, Donald, GB
NAZIR, Tahir, GB
|
| (73) |
LEO LABORATORIES LIMITED,
285 Cashel Road Crumlin, Dublin 2,
IE
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Terapinės kompozicijos, turinčios ingenol-3-angelato |
| THERAPEUTIC COMPOSITIONS COMPRISING INGENOL-3-ANGELATE |
| Payment date | Validity (years) | Amount | |
| 2019-12-03 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2020-07-11 |